Buffalo Early Stage Growth Fund HALO Holdings History
Buffalo Early Stage Growth Fund's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, Buffalo Early Stage Growth Fund held 26,210.00 shares of Halozyme Therapeutics Inc(HALO), totaling $1.67 Mil. This investment constitutes 2.95% of their stock portfolio, and Buffalo Early Stage Growth Fund now holds 0.02% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2023Q4. And since then Buffalo Early Stage Growth Fund has made 2 purchases of HALO, at an average price of $37.61, for a total of 33,710.00 shares. In addition, there have been 1 sales at an average price of $58.09 for 7,500.00 shares. Based on historical transaction data and HALO's current price of $58.77, Buffalo Early Stage Growth Fund's estimated gain on his HALO holdings is $708,303.10, reflecting a 55.87% gain to date.
Buffalo Early Stage Growth Fund HALO ($58.77) Holding Chart
Buffalo Early Stage Growth Fund HALO ($58.77) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
